e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Diffuse parenchymal lung disease I
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Evaluation and correlations of the extension of pulmonary cysts in lymphangioleiomyomatosis
M. Sponholz Araujo, C. Salim Gonçalves Freitas, B. Guedes Baldi, G. Borges da Silva Teles, S. Pinheiro Pimenta, D. Antunes Silva Pereira, O. Meira Dias, A. Nathan Costa, L. Kawano-Dourado, A. Kawassaki, R. Adib Kairalla, C. Roberto Ribeiro Carvalho (São Paulo, Brazil)
Source:
Annual Congress 2013 –Diffuse parenchymal lung disease I
Session:
Diffuse parenchymal lung disease I
Session type:
Thematic Poster Session
Number:
2342
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Sponholz Araujo, C. Salim Gonçalves Freitas, B. Guedes Baldi, G. Borges da Silva Teles, S. Pinheiro Pimenta, D. Antunes Silva Pereira, O. Meira Dias, A. Nathan Costa, L. Kawano-Dourado, A. Kawassaki, R. Adib Kairalla, C. Roberto Ribeiro Carvalho (São Paulo, Brazil). Evaluation and correlations of the extension of pulmonary cysts in lymphangioleiomyomatosis. Eur Respir J 2013; 42: Suppl. 57, 2342
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The new challenge of CTD-ILD: from basic science to clinical setting
Related content which might interest you:
The large airway lesions of lymphangioleiomyomatosis: Pathological and radiological analysis
Source: International Congress 2015 – IIPs: orphan
Year: 2015
Disease progression in IPF assessed using pulmonary function tests and functional respiratory imaging (FRI) – A pilot study
Source: International Congress 2014 – COPD and PAH related imaging
Year: 2014
IPFdatabase
– A new tool for a correct application of idiopathic pulmonary fibrosis guidelines
Source: International Congress 2014 – ILDs 2
Year: 2014
Clinical features and prognosis of 108 patients with lymphangioleiomyomatosis
Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations
Year: 2014
Lung
18
F-FDG uptake correlates with lung function alteration in patients with IPF
Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Year: 2014
European pulmonary alveolar proteinosis network (EuPAPNet): Results from biomarkers´ investigation
Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis
Year: 2014
Discovery and validation of peripheral blood gene expression profiles predictive of poor outcome and disease progression in idiopathic pulmonary fibrosis
Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis
Year: 2014
6MWT performance by means of Spiropalm in patients affected by fibrotic idiopathic interstitial pneumonias: Preliminary observations
Source: International Congress 2014 – ILDs 6
Year: 2014
3D-simulation in an integrated assessment of the dynamics in patients with disseminated pulmonary lesions (DPL)
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
Changes in pulmonary function in patients with lung tuberculoma
Source: Annual Congress 2013 –Tuberculosis: clinical aspects
Year: 2013
Clinical data, lung function and cardiopulmonary exercise testing in CPFE (combined pulmonary fibrosis with emphysema). Results of a cohort of 20 patients
Source: International Congress 2014 – ILDs 6
Year: 2014
Diffuse pulmonary ossification
Source: International Congress 2015 – Interstitial lung diseases I
Year: 2015
Annual changes in pulmonary function are independent prognostic factors for the patients with chronic hypersensitivity pneumonia
Source: International Congress 2014 – ILDs 3
Year: 2014
Comparison of physiological impairment in ILD patients with and without diagnostic IPF features
Source: International Congress 2014 – ILDs 4
Year: 2014
Lung functions and imaging characteristics of the patients with combined pulmonary fibrosis and emphysema
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
Pulmonary distribution and localization of pirfenidone in animal models of IPF by MS/MS
Source: International Congress 2014 – ILDs 4
Year: 2014
Correlation of high resolution CT patterns to pulmonary function tests in patients with interstitial lung diseases
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
Emphysema distribution determines distinct pulmonary function features
Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Year: 2013
Assessment of telomere length in the combined pulmonary fibrosis and emphysema syndrome
Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations
Year: 2014
Cystic lung disease with pulmonary amyloidosis: Analysis of 21 patients
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept